Citadel Advisors »

Aziyo Biologics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $50k 57k 0.89
2024-12-31 $84k 22k 3.74
2020-12-31 $1.5M 113k 13.48

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Aziyo Biologics

Nantahala Capital Management
AIGH Capital Management
Silverarc Capital Management
Alyeska Investment Group
Deerfield Management Company
Vanguard Group
Perkins Capital Management
Knollwood Investment Advisory
Birchview Capital
Geode Capital Management
BlackRock
Jane Street
Renaissance Technologies
Citadel Advisors
Millennium Management

View all funds holding Aziyo Biologics